Impaired glutamatergic and GABAergic function at early age in AβPPswe-PS1dE9 mice: Implications for Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 28, Issue 4, 2012, Pages 765-769

  Tiwari, Vivek ^a   Patel, Anant B ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Alzheimer's disease; GABA; glutamate; neuron glia trafficking; neurotransmitter cycle; nuclear magnetic resonance spectroscopy

Indexed keywords

GLUCOSE; GLUTAMIC ACID; GLUTAMINE DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; GLUCOSE OXIDATION; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84858012172     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111502     Document Type: Article

References (30)

1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
2. Basso M, Yang J, Warren L, MacAvoy MG, Varma P, Bronen RA, van Dyck CH (2006) Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry Res 146, 251-261. (Pubitemid 43782725)
3. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissinen A, Helkala EL, Vainio P, Vanninen R, Partanen K, Soininen H (2004) Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 25, 303-310. (Pubitemid 38220965)
4. Chen SQ, Wang PJ, Ten GJ, Zhan W, Li MH, Zang FC (2009) Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice. Dement Geriatr Cogn Disord 28, 558-566.
5. Lehericy S, Marjanska M, Mesrob L, Sarazin M, Kinkingnehun S (2007) Magnetic resonance imaging of Alzheimer's disease. Eur Radiol 17, 347-362. (Pubitemid 46150544)
6. Metastasio A, Rinaldi P, Tarducci R, Mariani E, Feliziani FT, Cherubini A, Pelliccioli GP, Gobbi G, Senin U, Mecocci P (2006) Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy. Neurobiol Aging 27, 926-932.
7. Ottersen OP, Storm-Mathisen J (1986) Excitatory amino acid pathways in the brain. Adv Exp Med Biol 203, 263-284.
8. Pearl PL, Gibson KM (2004) Clinical aspects of the disorders of GABA metabolism in children. Curr Opin Neurol 17, 107-113. (Pubitemid 38446450)
9. Sanacora G, Rothman DL, Mason G, Krystal JH (2003) Clinical studies implementing glutamate neurotransmission in mood disorders. Ann N Y Acad Sci 1003, 292-308. (Pubitemid 38083063)
10. Patel AB, de Graaf RA, Mason GF, Kanamatsu T, Rothman DL, Shulman RG, Behar KL (2004) Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation. J Cereb Blood Flow Metab 24, 972-985. (Pubitemid 39223621)
11. Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG (1998) Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A 95, 316-321. (Pubitemid 28103951)
12. Hyder F, Patel AB, Gjedde A, Rothman DL, Behar KL, Shulman RG (2006) Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab 26, 865-877. (Pubitemid 43980402)
13. Marjanska M, Curran GL, Wengenack TM, Henry PG, Bliss RL, Poduslo JF, Jack CR Jr, Ugurbil K, Garwood M (2005) Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 102, 11906-11910. (Pubitemid 41170823)
14. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: Evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13, 159-170. (Pubitemid 38111354)
15. Volianskis A, Kostner R, Molgaard M, Hass S, Jensen MS (2008) Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1deltaE9-deleted transgenic mice model of ss-amyloidosis. Neurobiol Aging 31, 1173-1187.
16. Richner M, Bach G, West MJ (2009) Over expression of amyloid beta-protein reduces the number of neurons in the striatum of APPswe/PS1DeltaE9. Brain Res 1266, 87-92.
17. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74, 5463-5467.
18. Chowdhury GM, Gupta M, Gibson KM, Patel AB, Behar KL (2007) Altered cerebral glucose and acetate metabolism in succinic semialdehyde dehydrogenase-deficient mice: Evidence for glial dysfunction and reduced glutamate/glutamine cycling. J Neurochem 103, 2077-2091. (Pubitemid 350126618)
19. Gengler S, Hamilton A, Holscher C (2010) Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice. PLoS One 5, e9764.
20. Xu F, Liu N, Kida I, Rothman DL, Hyder F, Shepherd GM (2003) Odor maps of aldehydes and esters revealed by functional MRI in the glomerular layer of the mouse olfactory bulb. Proc Natl Acad Sci U S A 100, 11029-11034. (Pubitemid 37140147)
21. Fitzpatrick SM, Hetherington HP, Behar KL, Shulman RG (1990) The flux from glucose to glutamate in the rat brain in vivo as determined by 1H-observed, 13C-edited NMR spectroscopy. J Cereb Blood Flow Metab 10, 170-179. (Pubitemid 20096187)
22. de Graaf RA, Brown PB, Mason GF, Rothman DL, Behar KL (2003) Detection of [1,6-13C2]-glucose metabolism in rat brain by in vivo 1H-[13C]-NMR spectroscopy. Magn Reson Med 49, 37-46. (Pubitemid 36042332)
23. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE, Diamond DM (2001) Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891, 42-53. (Pubitemid 32115494)
24. Bryan KJ, Lee H, Perry G, Smith MA, Casadesus G (2009) Transgenic mouse models of alzheimer's disease: Behavioral testing and considerations. In: Methods of Behavior Analysis in Neuroscience, Buccafusco JJ, ed., Taylor&Francis Group, Boca Raton, FL, pp. 1-18.
25. Yu Y, He J, Zhang Y, Luo H, Zhu S, Yang Y, Zhao T, Wu J, Huang Y, Kong J, Tan Q, Li XM (2009) Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model. Hippocampus 19, 1247-1253.
26. von Kienlin M, Kunnecke B, Metzger F, Steiner G, Richards JG, Ozmen L, Jacobsen H, Loetscher H (2005) Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiol Dis 18, 32-39. (Pubitemid 40092895)
27. Dubois A, Herard AS, Delatour B, Hantraye P, Bonvento G, Dhenain M, Delzescaux T (2010) Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease. Neuroimage 51, 586-598.
28. Lebenberg J, Herard AS, Dubois A, Dauguet J, Frouin V, Dhenain M, Hantraye P, Delzescaux T (2010) Validation of MRI-based 3D digital atlas registration with histological and autoradiographic volumes: An anatomofunctional transgenic mouse brain imaging study. Neuroimage 51, 1037-1046.
29. Kim EJ, Cho SS, Jeong Y, Park KC, Kang SJ, Kang E, Kim SE, Lee KH, Na DL (2005) Glucose metabolism in early onset versus late onset Alzheimer's disease: An SPM analysis of 120 patients. Brain 128, 1790-1801. (Pubitemid 41373650)
30. Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ (2010) Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 133, 512-528.